相似文献
1
Campylobacter jejuni is not an important pathogen as a cause of diarrhea in US travelers to Mexico.
J Travel Med. 2011 Jan-Feb;18(1):56-8. doi: 10.1111/j.1708-8305.2010.00469.x. Epub 2010 Nov 22.
2
Human serum antibody response in Campylobacter jejuni enteritis as measured by enzyme-linked immunosorbent assay.
Eur J Clin Microbiol Infect Dis. 1988 Jun;7(3):388-93. doi: 10.1007/BF01962343.
3
Evaluation of antibodies reactive with Campylobacter jejuni in Egyptian diarrhea patients.
Clin Diagn Lab Immunol. 1997 Sep;4(5):536-9. doi: 10.1128/cdli.4.5.536-539.1997.
4
Antibody responses to Campylobacter infections determined by an enzyme-linked immunosorbent assay: 2-year follow-up study of 210 patients.
Clin Diagn Lab Immunol. 2001 Mar;8(2):314-9. doi: 10.1128/CDLI.8.2.314-319.2001.
5
Campylobacter jejuni as a cause of traveler's diarrhea: clinical features and antimicrobial susceptibility.
J Travel Med. 1998 Mar;5(1):23-6. doi: 10.1111/j.1708-8305.1998.tb00451.x.
6
Diffusion-in-gel enzyme-linked immunosorbent assay for routine detection of IgG and IgM antibodies to Campylobacter jejuni.
J Infect Dis. 1983 Jul;148(1):82-92. doi: 10.1093/infdis/148.1.82.
7
Establishment of a non-human primate Campylobacter disease model for the pre-clinical evaluation of Campylobacter vaccine formulations.
Vaccine. 2006 May 1;24(18):3762-71. doi: 10.1016/j.vaccine.2005.07.023. Epub 2005 Jul 25.
8
Enterotoxigenic Escherichia coli heat-labile toxin seroconversion in US travelers to Mexico.
J Travel Med. 2008 May-Jun;15(3):156-61. doi: 10.1111/j.1708-8305.2008.00187.x.
9
[Serological response to Campylobacter jejuni infection: enzyme-linked immunosorbent assay (ELISA) for detection of antibodies to Campylobacter jejuni].
Kansenshogaku Zasshi. 1982 Jul;56(7):566-73. doi: 10.11150/kansenshogakuzasshi1970.56.566.
10
ELISA for Campylobacter jejuni antibodies in Israeli children with diarrhea and in healthy soldiers.
Isr J Med Sci. 1990 Jun;26(6):319-24.
引用本文的文献
1
Advances in the treatment of travelers' diarrhea.
Curr Gastroenterol Rep. 2011 Oct;13(5):402-7. doi: 10.1007/s11894-011-0208-6.
本文引用的文献
1
Systematic review: the epidemiology and clinical features of travellers' diarrhoea.
Aliment Pharmacol Ther. 2009 Aug;30(3):187-96. doi: 10.1111/j.1365-2036.2009.04028.x. Epub 2009 Apr 21.
2
Enterotoxigenic Escherichia coli heat-labile toxin seroconversion in US travelers to Mexico.
J Travel Med. 2008 May-Jun;15(3):156-61. doi: 10.1111/j.1708-8305.2008.00187.x.
3
Treatment of travelers' diarrhea: randomized trial comparing rifaximin, rifaximin plus loperamide, and loperamide alone.
Clin Gastroenterol Hepatol. 2007 Apr;5(4):451-6. doi: 10.1016/j.cgh.2007.02.004. Epub 2007 Mar 26.
4
Incidence, etiology, and impact of diarrhea among deployed US military personnel in support of Operation Iraqi Freedom and Operation Enduring Freedom.
Am J Trop Med Hyg. 2006 Oct;75(4):762-7.
5
Incidence, etiology, and impact of diarrhea among long-term travelers (US military and similar populations): a systematic review.
Am J Trop Med Hyg. 2006 May;74(5):891-900.
6
Campylobacter jejuni as a cause of traveler's diarrhea: clinical features and antimicrobial susceptibility.
J Travel Med. 1998 Mar;5(1):23-6. doi: 10.1111/j.1708-8305.1998.tb00451.x.
7
Seasonal variation in etiology of travelers' diarrhea. Finnish-Moroccan Study Group.
J Infect Dis. 1992 Feb;165(2):385-8. doi: 10.1093/infdis/165.2.385.
Zotero 插件